Advances in Gene Therapy (TechVision)

Advances in Gene Therapy (TechVision)

Technology and Market Trends

RELEASE DATE
28-Sep-2015
REGION
North America
Research Code: D6BA-01-00-00-00
SKU: HC02420-NA-TR_16542
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02420-NA-TR_16542

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The objective of this research service is to provide an exhaustive analysis of the current trends in gene therapy. The research service comprises details of technology challenges, market drivers and restraints in addition to the competitive landscape present in the gene therapy market space. The research service analyzes the recent developments in companies with respect to a variety of diseases application areas. A thorough and exhaustive overview of product candidates and the phases of clinical trial development across the United states is provided.

The information in this research service will detail the areas in gene therapy that are experiencing significant growth in the United States, with associated and pertinent advancements around the globe. It will clearly breakdown the key success indicators, that have shown to hold positive outlook for commercialization over the short term future.

Table of Contents

Scope

Methodology

Introduction

Gene Therapy, Event Timeline, 1997-2014

Gene Therapy, Event Timeline, 1997-2014

Gene Therapy, Event Timeline, 1997-2014

Technology Readiness Level Approach

Technology Segments

Technology Segments (continued)

Non viral vectors

Non viral vectors

Viral Vectors

Viral Vectors (continued)

Viral Vectors (continued)

Viral Vectors (continued)

Viral Vectors (continued)

Viral Vectors (continued)

Gene Types

Introduction

Segmentation by Disease area

Monogenic Disease

Monogenic Disease (continued)

Monogenic Disease (continued)

Monogenic Disease: Product Reservoir

Monogenic Disease: Product Reservoir (continued)

Monogenic Disease: Product Reservoir (continued)

Cancer Disease

Cancer Disease (continued)

Cancer Disease: Product Reservoir

Cancer Disease: Product Reservoir (continued)

Cancer Disease: Product Reservoir (continued)

Cardiovascular Diseases

Cardiovascular Disease (continued)

Cardiovascular Disease: Product Reservoir

Other Diseases

Other Disease: Product Reservoir

Other Disease: Product Reservoir (continued)

Gene Therapy Products on the Horizon

Emerging disease areas

Venture Capital Funding Assessment

Venture Capital Funding Assessment (continued)

Role of Big Pharma

Role of Big Pharma (continued)

Clinical Trials Overview

Drivers

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Restraints

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Company Profiles

Company Profile

Company Profile

Company Profile

Company Profile

Company Profile

Company Profile

Company Profile

Company Profile

Company Profile

Company Profile

Company Profile

Legal Disclaimer

Glossary

Glossary (continued)

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
The objective of this research service is to provide an exhaustive analysis of the current trends in gene therapy. The research service comprises details of technology challenges, market drivers and restraints in addition to the competitive landscape present in the gene therapy market space. The research service analyzes the recent developments in companies with respect to a variety of diseases application areas. A thorough and exhaustive overview of product candidates and the phases of clinical trial development across the United states is provided. The information in this research service will detail the areas in gene therapy that are experiencing significant growth in the United States, with associated and pertinent advancements around the globe. It will clearly breakdown the key success indicators, that have shown to hold positive outlook for commercialization over the short term future.
More Information
No Index No
Podcast No
Author Madhumitha Rangesa
Industries Healthcare
WIP Number D6BA-01-00-00-00
Keyword 1 Gene Therapy
Keyword 2 gene therapy technologies
Keyword 3 Cancer Gene Therapy
Is Prebook No